Avanzanite Partners with Agios to Launch PYRUKYND Across Europe
June 9, 2025
PYRUKYND® (mitapivat) is a first-in-class pyruvate kinase (PK) activator, approved by the European Commission for adults with PK deficiency Avanzanite Bioscience B.V., a fast-growing commercial-stage